Hong Kong Tobacco Stock News

The Asian markets have been a focal point for investors as they navigate the complexities of global economic shifts, with China's consumer inflation easing and Japan's stock markets experiencing gains. For those interested in exploring beyond the well-trodden paths of large-cap stocks, penny stocks—despite their somewhat outdated moniker—continue to present intriguing opportunities. These smaller or newer companies can offer significant value, especially when they possess strong financial...

Why InSilico Medicine Cayman TopCo is on investors’ radar InSilico Medicine Cayman TopCo (SEHK:3696) has recently caught attention after a strong share price move, including an 18.3% return over the past week and 33.3% over the past month. See our latest analysis for InSilico Medicine Cayman TopCo. The recent jump in InSilico Medicine Cayman TopCo’s share price, with a 7 day share price return of 18.3% and 30 day share price return of 33.3%, sits within a much stronger year to date share...

China Conch Venture Holdings (SEHK:586) has issued its first tranche of 2026 green medium term notes, raising RMB1.235 billion at a 1.9% coupon. The notes are rated AAA by China Lianhe Credit Rating. See our latest analysis for China Conch Venture Holdings. The green note issue comes after a strong run in the shares, with a 1 month share price return of 25.80% and a year to date share price return of 26.46%. The 1 year total shareholder return of 91.44% contrasts with weaker 3 and 5 year...

What Cirrus Aircraft’s G3 Vision Jet Launch Means For Shareholders Cirrus Aircraft (SEHK:2507) has just begun delivering its Generation 3 Vision Jet, featuring an expanded seven seat layout, refreshed interior materials, and updated avionics including ATC Datalink and other flight deck refinements. This product launch gives investors a fresh reference point to consider Cirrus Aircraft’s position in personal aviation, in the context of its existing revenue of HK$1,316.235 million and net...

Why Suzhou Ribo Life Science Is Drawing Investor Attention Suzhou Ribo Life Science (SEHK:6938) has come onto investors’ radar after a month return of about 8% decline, extending a weaker year to date performance and raising fresh questions about sentiment toward its small nucleic acid drug pipeline. See our latest analysis for Suzhou Ribo Life Science. The latest 1 day share price return of a 5.40% decline, on a last close of HK$70.05, sits against a 7 day share price return of 1.08% and a...

Akeso (SEHK:9926) has just received approval in China to start Phase II trials for AK139, a first in class IL-4Ra/ST2 bispecific antibody, targeting seven respiratory and autoimmune conditions. See our latest analysis for Akeso. Investors seem to be weighing Akeso's busy clinical calendar against recent volatility, with a 1 day share price return of 1.54% and 7 day return of 4.36% following the AK139 and ivonescimab updates. The 1 year total shareholder return of 74.92% points to strong...

Alphamab Oncology (SEHK:9966) has dosed the first patient in its Phase III trial of JSKN003 for HER2-positive advanced colorectal cancer, marking a key milestone for this antibody-drug conjugate following its Breakthrough Therapy Designation in China. See our latest analysis for Alphamab Oncology. The JSKN003 milestone comes after a mixed run in the shares, with a 1-year total shareholder return of 124.81% contrasting with a 30-day share price return decline of 12.74% and longer term 3 and 5...

Axera Semiconductor (SEHK:600) has recently drawn attention after a sharp 17.2% one-day move in its share price, prompting investors to reassess how its current valuation lines up with its business fundamentals. See our latest analysis for Axera Semiconductor. That 17.2% one day share price return at HK$28.26 sits against a relatively flat year to date share price return of 0.21%. This suggests the latest move may reflect a sudden shift in how the market views Axera Semiconductor’s growth...

Semiconductor Manufacturing International Corporation reported fourth-quarter 2025 results with sales of US$2,488.71 million and net income of US$172.85 million, and later issued first-quarter 2026 guidance indicating sequentially flat revenue and an 18%–20% gross margin range. This combination of solid quarterly profitability and a cautious margin outlook gives investors fresh insight into how SMIC is balancing growth with profitability pressures. Next, we’ll examine how SMIC’s guidance for...

BYD stock performance snapshot BYD (SEHK:1211) has recently seen mixed share performance, with a 0.8% decline over the past day, a 5.9% gain over the past week, and a small pullback over the past month. Over longer periods, BYD shows a 1.0% negative return year to date, an 18.6% negative total return over the past year, and positive total returns across the past 3 and 5 years, highlighting both volatility and staying power. The shares last closed at HK$97.75, with recent annual revenue of...

Attention on Tencent Holdings (SEHK:700) has picked up after DBS Bank and TenPay Global launched a new cross-border service that links DBS accounts with Weixin Pay and expands DBS PayLah! acceptance across mainland China. See our latest analysis for Tencent Holdings. Despite the new DBS and TenPay Global tie up highlighting Tencent's role in cross border payments, the shares trade at HK$532.0 after a 14.47% 1 month share price decline. The 1 year total shareholder return of 13.03% contrasts...

With its stock down 7.8% over the past three months, it is easy to disregard Johnson Electric Holdings (HKG:179...

Lenovo Group (SEHK:992) is restructuring its Infrastructure Solutions Group to place greater emphasis on AI driven offerings. The company is expanding AI centric products and services while dealing with an industry wide crunch in memory chip supply. Management is prioritizing cost savings and new AI enabled hardware and infrastructure solutions to adapt its operations and product mix. For you as an investor, the key point is that Lenovo is reshaping a core infrastructure business around AI...

Key Insights The projected fair value for China Literature is HK$59.55 based on 2 Stage Free Cash Flow to Equity China...

AIA Group (SEHK:1299) has appointed Ms. Shulamite Khoo and Mr. Ku Man as Independent Non executive Directors. Both appointees bring extensive experience across insurance, banking and international executive roles. Their appointments expand the board’s mix of industry, financial and governance expertise. AIA Group focuses on life and health insurance, with a footprint across multiple Asia Pacific markets. Fresh board appointments are often closely watched by investors, as they can influence...

One simple way to benefit from the stock market is to buy an index fund. But if you pick the right individual stocks...

The board of Langham Hospitality Investments Limited ( HKG:1270 ) has announced that it will be increasing its dividend...

Bank of East Asia (SEHK:23) has just posted its FY 2025 first half results, with total revenue of HK$7.7b and basic EPS of HK$0.86, alongside net income of HK$2.3b. The bank reported revenue of HK$7.5b and EPS of HK$0.69 in the first half of 2024, followed by revenue of HK$7.9b and EPS of HK$0.84 in the second half of 2024. As a result, FY 2025 starts after three consecutive reported periods of higher earnings per share. With that backdrop, investors are likely to focus on how its net...

China Tobacco International (HK) (HKG:6055) has had a great run on the share market with its stock up by a significant...

Key Insights Tanwan's significant insider ownership suggests inherent interests in company's expansion Xubo Wu owns 54...

Macau Legend Development Limited ( HKG:1680 ) shares have had a horrible month, losing 26% after a relatively good...

Most readers would already be aware that CM Energy Tech's (HKG:206) stock increased significantly by 75% over the past...

Star Shine Holdings Group Limited ( HKG:1440 ) shares have had a really impressive month, gaining 25% after a shaky...

What trends should we look for it we want to identify stocks that can multiply in value over the long term? One common...